Advertisement
Home »

Statistical analysis plan for the PRO B study: open-label, superiority randomised controlled trial of alarm-based patient-reported outcome monitoring in patients with metastatic breast cancer.

Mar 07, 2024

ABOUT THE EXPERTS

  • Pimrapat Gebert

    Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany. pimrapat.gebert@charite.de.

    Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany. pimrapat.gebert@charite.de.

    Maria Margarete Karsten

    Department of Gynecology with Breast Center, Charité – Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.

    Anna Maria Hage

    Department of Gynecology with Breast Center, Charité – Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.

    Adam David Dordevic

    Department of Gynecology with Breast Center, Charité – Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.

    Ulrike Grittner

    Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.

    Institute of Biometry and Clinical Epidemiology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement